Views & Analysis Adding value to generics and biosimilars Paul Tredwell, vice president for specialty brands at Accord Healthcare says innovation is vital for success in today’s generics and biosimilars market.
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.